Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 15 JULY 2022

Protection des marques de commerce au sein des domaines des chaînes de blocs

Fasken
Explore more from Fasken

Les sociétés propriétaires d'une marque de commerce devraient réserver leurs marques auprès des systèmes de nommage sur la chaîne de blocs.

CanadaIntellectual Property
Anne-Sophie Godbout
Anne-Sophie Godbout
Nicolas Charest
Nicolas Charest
Alexandra Lemelin
Alexandra Lemelin
Author LinkedIn connections

Protection des marques de commerce au sein des domaines des chaînes de blocs

Les sociétés propriétaires d'une marque de commerce devraient réserver leurs marques auprès des systèmes de nommage sur la chaîne de blocs. Les risques de contrefaçon au niveau des domaines de chaînes de blocs sont réels et les remèdes sont limités pour le moment. Ainsi, il devient essentiel de protéger en amont les droits de propriété intellectuelle des entreprises au sein de l'écosystème des chaînes de blocs.

1. Contexte

La chaîne de blocs est une technologie décentralisée, dans la mesure où chaque nSud (ou ordinateur) du réseau a accès au registre complet des transactions. Chaque transaction est traçable et infalsifiable. Dans cet écosystème, les systèmes de nommage sur la chaîne de blocs (similaire aux domaines traditionnels, comme par exemple .com ou .ca) permettent, entre autres, aux sociétés d'identifier plus facilement les portefeuilles où recevoir ou envoyer des paiements

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules

A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
Article

Canada’s Counter-Tariffs On US Goods: A Primer On What Canadian Businesses Need To Know

Effective September 8, 2026, Canada implemented retaliatory tariffs on certain U.S. goods in response to the initial 50% tariffs imposed by the US under Section 338 of the Tariff Act of 1930. To operationalize these measures, the Canada Border Services Agency (CBSA) issued Customs Notice 26-23, establishing binding administrative rules on how the surtax will be applied, calculated, and collected.
CanadaInternational Law
Fasken
Fasken
Article

Open Banking Milestone: Draft Supervisory Guidelines For Consumer-Driven Banking Released

The Bank of Canada (the “Bank”) has published two proposed guidelines relating to the accreditation process for prospective participants under the Consumer-Driven Banking Framework: the Participating entity accreditation application requirements under the Consumer-Driven Banking Act (the “Participating Entity Guideline”) and the Third-party service provider accreditation application requirements under the Consumer-Driven Banking Act (the “TPSP Guideline”).
CanadaFinance and Banking
Fasken
Fasken
Article

Life Sciences-Health Canada Takes Action Against Unauthorized Peptide Sales

On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
Article

Buying Quebec, Buying Canadian: What The New Orders In Council 1358-2026 And 1359-2026 Mean For Procurement

Under Order in Council 1358-2026, the Québec government authorizes, from September 7, 2026 to January 31, 2027, the Centre d'acquisitions gouvernementales (the “CAG”) to depart from the general principle that public calls for tenders must be open and without discrimination to foreign suppliers from jurisdictions bound by an intergovernmental agreement with Québec.
CanadaGovernment, Public Sector
Fasken
Fasken